Sylfirm X and Morpheus8 are two of the most widely adopted radiofrequency microneedling technologies in modern aesthetic practice. Both systems utilise bipolar radiofrequency energy delivered through microneedles to induce controlled thermal injury, stimulate collagen remodelling, and improve overall skin quality. At first glance, they appear to operate on similar principles, and indeed, both are effective tools in the management of skin laxity and textural concerns. However, when examined more closely from an engineering and clinical perspective, important differences emerge that influence treatment precision, safety, patient experience, and overall versatility.
Esthetician + Spa Owner Reviews L+A
Christina Willis, LE + Spa Owner
L+A brings solution options to the forefront for professionals to share with clients, and does an incredible deep dive verifying skin treatments through personal testing, professional assessment, or ingredient analysis. Which is why they are my TRUSTED go to resource. Their process helps ensure that a product actually works as claimed.
There is a welcomed sense of community and camaraderie at the root of L+A. They bring together and celebrate innovative and forward thinking estheticians. Their investigative reporting excites and keeps me motivated feeling fresh with confidence.
I believe the work they share has the potential to make me a better esthetician. Thank you L+A!
Differences Between Sylfirm X and Morephus8
Both devices are based on bipolar radiofrequency, meaning that electrical current flows between electrodes within a confined treatment zone. This allows for controlled energy delivery compared to monopolar systems. However, the behaviour of that energy within the tissue differs between the two platforms. Sylfirm X operates at approximately 2 MHz, while Morpheus8 operates at around 1 MHz. It is important to clarify that frequency alone does not determine depth of penetration, as this is primarily governed by needle depth and treatment settings. The more meaningful distinction is in how energy is distributed. In clinical practice, the higher frequency used by Sylfirm X produces a more stable and controlled energy profile with less bulk heating of surrounding tissue, whereas the lower frequency used by Morpheus8 tends to create a broader thermal spread. This difference is often reflected in patient feedback, with Sylfirm X treatments generally being perceived as more comfortable.
Design of Sylfirm X and Morpheus8 Microneedles
The design of the microneedles further differentiates the two technologies. Morpheus8 uses insulated needles, which concentrate energy delivery at the tip of the needle. This creates focal zones of thermal injury within the dermis, which can be advantageous for deeper structural remodelling. However, this concentrated delivery can also increase the risk of focal overheating and visible post-treatment marks. Sylfirm X uses non-insulated needles, meaning that the entire needle shaft acts as an active electrode. This allows energy to be distributed more evenly throughout the dermis, resulting in a more uniform thermal effect. Clinically, this often translates into a lower risk of post-inflammatory hyperpigmentation and reduced incidence of grid-like marks on the skin, particularly in patients with higher Fitzpatrick skin types.
Dr. Vincent Wong, L+A Medical Contributor
Dr. Vincent Wong is a leading cosmetic doctor based in London. He specialises in facial balancing, masculinisation and feminisation using non-surgical and minimally invasive techniques. GMC registered, he holds a Bachelor of Science in Medicine (First Class Honours) from the University of St Andrews and a Bachelor of Medicine and Surgery from the University of Aberdeen.
Dr. Vincent has won a number of awards for his work and has been shortlisted as one of Forbes’s Top 10 emerging doctors as well as NYC Journal’s 50 under 50 and Best Researcher Award from the International Academic Awards. He is also on the judging panel for Miss Universe Great Britain. He released a textbook in Aesthetic Medicine in 2021 and is actively involved in research with over 35 scientific publications. Dr. Vincent works closely with major pharmaceutical companies in the field as a Global Advisor and lectures internationally.
With his extensive experience in the field of non-surgical aesthetics, he is also the creator of the world-renowned R-Technique, an innovative way of injecting dermal fillers to give patients a natural, refreshed look. Dr. Vincent aims to continue pushing boundaries, exploring innovative solutions, and ensuring that every patient receives personalized care that meets their specific needs and aspirations.
We thank Dr Wong for his contribution. All opinions expressed are those of the individual contributor and do not reflect the views of Lipgloss + Aftershave. Any statements regarding devices, technologies, or outcomes are based on the contributor’s personal experience or perspective, and Lipgloss + Aftershave assumes no responsibility for such claims.
Sylfirm X NA Effect
A defining feature of Sylfirm X is what is described as the Na effect. This refers to a specific pattern of electrothermal coagulation that forms around each non-insulated needle electrode during energy delivery. Coagulation begins at the tip and expands upward and laterally along the needle, forming a controlled, cocoon-like thermal zone within the dermis while minimising disruption to the epidermis. This controlled coagulation pattern allows for effective treatment of target tissue with reduced collateral damage. By comparison, Morpheus8 relies on more focal thermal zones created at the insulated needle tips, which, while effective, do not demonstrate the same degree of controlled spatial distribution.
Closely related to this is the way energy propagates between needles. In Sylfirm X, the needles themselves are charged, allowing energy to travel not only vertically but also horizontally between adjacent electrodes. As conduction time increases, inter-electrode currents develop, creating a lateral spread of energy within the dermis. This results in a more uniform treatment field and avoids excessive concentration of energy in a single point. In practical terms, this pattern of energy distribution enhances safety, particularly in delicate anatomical areas. For example, Sylfirm X can be used in the periorbital region, including the eyelids, with a high degree of confidence, as the energy remains controlled within the dermal plane rather than extending unpredictably into deeper structures. Morpheus8, while effective, does not demonstrate the same degree of controlled horizontal energy propagation.
Treatment Depth Capabilities
Another important distinction lies in treatment depth capabilities. Sylfirm X can deliver energy at depths as shallow as 0.3 mm, allowing clinicians to target the papillary dermis and dermo-epidermal junction. This is particularly relevant in conditions such as melasma, post-inflammatory hyperpigmentation, and vascular disorders, where pathology exists in the superficial dermis. Morpheus8 is generally used at deeper depths, typically between 1 and 4 mm, making it well-suited for structural remodelling and skin tightening but less adaptable for superficial pathology. As a result, the clinical scope of Sylfirm X extends beyond collagen stimulation into the treatment of pigmentary and vascular conditions.
Slyfirm X Dual-Wave Technology
In addition, Sylfirm X incorporates dual-wave technology, offering both continuous wave and pulsed wave modes. Continuous wave energy is used for conventional collagen remodelling, while pulsed wave energy allows for selective targeting of abnormal vasculature. This is particularly useful in conditions such as melasma and rosacea, where vascular dysregulation contributes to disease persistence. Morpheus8 does not offer an equivalent pulsed wave mechanism, and its effects are therefore largely limited to thermal remodelling rather than selective vascular targeting.
Patient Experience
From the perspective of patient experience, these differences are clinically relevant. Sylfirm X treatments are generally associated with lower levels of discomfort, reduced inflammation, and shorter downtime. Morpheus8 treatments, while effective, are often perceived as more aggressive, with greater intra-procedural discomfort and a higher likelihood of visible post-treatment effects. In a clinical setting where patient compliance and repeat treatments are essential for optimal outcomes, these factors play a significant role.
Sylfirm X Offers Broader Range of Capabilities
When comparing the two devices, it becomes clear that both have strengths. Morpheus8 is a well-established system that performs effectively in deeper dermal remodelling and skin tightening. However, Sylfirm X offers a broader range of capabilities, including superficial treatment, vascular targeting, and improved safety in delicate areas, alongside a more comfortable patient experience.
For practitioners evaluating which platform provides the greatest overall utility, the distinction ultimately lies in versatility and precision. While Morpheus8 remains a useful tool for specific indications, Sylfirm X demonstrates a higher level of control in energy delivery, a more sophisticated interaction with tissue, and a wider clinical application. On balance, this makes Sylfirm X the more advanced and adaptable technology, and in my experience, the more effective choice for delivering consistent, high-quality outcomes across a diverse range of aesthetic concerns.